Patents Examined by Pensee Do
  • Patent number: 9267868
    Abstract: An automated microscope slide staining system and staining apparatus and method that features a plurality of individually operable miniaturized pressurizable reaction compartments or a pressurizable common chamber for individually and independently processing a plurality of microscope slides. The apparatus preferably features independently movable slide support elements each having an individually operable heating element.
    Type: Grant
    Filed: July 16, 2013
    Date of Patent: February 23, 2016
    Inventor: Lee H. Angros
  • Patent number: 9267943
    Abstract: Described here is an automated robotic device that isolates circulating tumor cells (CTCs) or other biological structures with extremely high purity. The device uses powerful magnetic rods covered in removable plastic sleeves. These rods sweep through blood samples, capturing, e.g., cancer cells labeled with antibodies linked to magnetically responsive particles such as superparamagnetic beads. Upon completion of the capturing protocol, the magnetic rods undergo several rounds of washing, thereby removing all contaminating blood cells. The captured target cells are released into a final capture solution by removing the magnetic rods from the sleeves. Additionally, cells captured by this device show no reduced viability when cultured after capture. Cells are captured in a state suitable for genetic analysis. Also disclosed are methods for single cell analysis. Being robotic allows the device to be operated with high throughput.
    Type: Grant
    Filed: October 28, 2011
    Date of Patent: February 23, 2016
    Assignee: The Board of Trustees of the Leland Stanford Junior University
    Inventors: Ronald W. Davis, Stefanie S. Jeffrey, Michael N. Mindrinos, R. Fabian Pease, Ashley Ann Powell, AmirAli Hajhossein Talasaz
  • Patent number: 9115384
    Abstract: The invention provides methods and compositions for simultaneously detecting the activation state of a plurality of proteins in single cells using flow cytometry. The invention further provides methods and compositions of screening for bioactive agents capable of coordinately modulating the activity of a plurality of proteins in single cells. The methods and compositions can be used to determine the protein activation profile of a cell for predicting or diagnosing a disease state, and for monitoring treatment of a disease state.
    Type: Grant
    Filed: May 2, 2011
    Date of Patent: August 25, 2015
    Assignee: The Board of Trustees of the Leland Stanford Junior University
    Inventors: Omar D. Perez, Garry P. Nolan
  • Patent number: 9097675
    Abstract: An assay and method of making same for use in SERS spectroscopy. The assay includes colloidal particles of a metal, which have been lyophilized. The lyophilized particles of metal produce a SERS active solution when reconstituted. The lyophilized particles of metal may be provided in a container in an assay system.
    Type: Grant
    Filed: June 15, 2011
    Date of Patent: August 4, 2015
    Assignee: University of Wyoming
    Inventors: Keith T. Carron, Bryan Hubert Ray, Roberta A. Sulk
  • Patent number: 9068978
    Abstract: Optical measurement methods are described that are suitable for determining the relaxation behavior of nanoparticles dispersed in a solution. The particles have optically anisotropic properties and are alignable by an external stimulus, for example, an electric or magnetic field. In this manner the optical detection of certain molecules that can bind specifically to the surface of the nanoparticles and thus change the relaxation behavior of the nanoparticles as well as to provide devices for carrying out the methods is possible.
    Type: Grant
    Filed: October 13, 2009
    Date of Patent: June 30, 2015
    Assignees: Tecnet Equity NOE Technologiebeteiligungs-Invest GmbH, AIT Austrian Institute of Technology GmbH
    Inventors: Hubert Brückl, Jörg Schotter, Ole Bethge
  • Patent number: 9063044
    Abstract: Provided herein are magnetic aggregating and washing devices. Further provided herein are methods using magnetic aggregation to aggregate and wash sample molecules in an in vitro assay.
    Type: Grant
    Filed: February 27, 2013
    Date of Patent: June 23, 2015
    Assignee: PLEXBIO CO. LTD.
    Inventors: Chien-Teng Kao, Yao-Kuang Chung, Pei-San Lee
  • Patent number: 8999731
    Abstract: The present application provides a set of fundamental operations enabling interactive control over the creation and placement of planar arrays of several types of particles and biomolecules and the manipulation of array shape and size. The present invention enables sample preparation and handling for diagnostic assays and biochemical analysis in an array format, and the functional integration of these operations. In addition, the present invention provides a procedure for the creation of material surfaces with desired properties and for the fabrication of surface-mounted optical components.
    Type: Grant
    Filed: December 21, 2011
    Date of Patent: April 7, 2015
    Assignee: BioArray Solutions, Ltd.
    Inventors: Michael Seul, Chiu Wo Chau
  • Patent number: 8999732
    Abstract: The invention relates to a method of handling and mixing magnetic particles within a reaction chamber that is part of a microfluidic device and that contains the said particles in suspension. More particularly, the invention concerns a method of handling magnetic particles in a way to improve the mixing of the particles with the surrounding liquids medium and where the liquid is carried by a fluid flow as part of an automated system. Further, the invention describes the use of the method for conducting biological and chemical assays.
    Type: Grant
    Filed: December 19, 2008
    Date of Patent: April 7, 2015
    Assignee: Spinomix, S.A.
    Inventor: Amar Rida
  • Patent number: 8945469
    Abstract: A magnetic immunoassay system with a mechanism for compensating the direct current residual magnetic field in the vicinity of the specimen measurement position, in a direction perpendicular to the magnetic marker direction of magnetization for the measurement target. This invention reduces the effects of the magnetic field emitted from the unbound magnetic marker due to the residual magnetic field in the specimen solution and detects with high sensitivity the signal of the bound target magnetic marker. The magnetic field at the measurement position is regulated so as to intersect the direction of magnetization of the magnetic marker for the measurement target, in order to make the magnetization direction of the magnetic marker that is unbound due to residual magnetism or remanence in the sample solution, intersect the magnetization direction of the magnetic marker for the measurement target.
    Type: Grant
    Filed: March 9, 2007
    Date of Patent: February 3, 2015
    Assignee: Hitachi, Ltd.
    Inventors: Akira Tsukamoto, Kazuo Saitoh
  • Patent number: 8936946
    Abstract: The disclosure generally relates to a particulate composition formed from a conductive polymer (e.g., conductive polyanilines, polypyrroles, polythiophenes) bound to magnetic nanoparticles (e.g., Fe(II)- and/or Fe(III)-based magnetic metal oxides). The particulate composition can be formed into a biologically enhanced, electrically active magnetic (BEAM) nanoparticle composition by further including a binding pair member (e.g., an antibody) bound to the conductive polymer of the particulate composition. Methods and kits employing the particulate composition and the BEAM nanoparticle composition also are disclosed.
    Type: Grant
    Filed: June 18, 2008
    Date of Patent: January 20, 2015
    Assignee: Board of Trustees of Michigan State University
    Inventors: Evangelyn C. Alocilja, Sudeshna Pal, Emma B. Setterington
  • Patent number: 8889429
    Abstract: A dual-interaction ligand for rendering otherwise hydrophobic nanoparticles water soluble or suspendable has a hydrophilic base with a plurality of hydrophilic segments extending from a core of the base, where at least one segment or the core contains a hydrophobic groups capable of forming van der Waal interaction between hydrophobic groups of the dual-interaction ligand and other hydrophobic ligands, and at least one complexing functionality to complex a metal atom or ion of a nanoparticle. The dual-interaction ligands can be combined with hydrophobic nanoparticles, where the dual-interaction ligands can displace some or all of the hydrophobic ligands of the hydrophobic nanoparticles, to form a nanoparticle-dual interaction ligand complex that can be dissolved or dispersed readily in an aqueous solution. The dual interaction ligand can be functionalized to attach an antibody or other biomolecules such that the nanoparticle dual-interaction ligands complexes can contain biomolecules.
    Type: Grant
    Filed: January 28, 2009
    Date of Patent: November 18, 2014
    Assignee: University of Florida Research Foundation, Inc.
    Inventors: Y. Charles Cao, Huimeng Wu
  • Patent number: 8883519
    Abstract: Methods, systems, compositions include biocompatible polymer coated nanoceria that function as aqueous redox catalyst with enhanced activity at an acidic to moderately alkaline pH value between 1 and 8. The compositions are used as oxidizing agents for decomposition, decontamination or inactivation of organic contaminants, such as, pesticides and chemical warfare agents. Another use includes nanoceria as targetable nanocatalyst prepared by conjugating various targeting ligands to the nanoparticle coating to form a colorimetric or fluorescent probe in immunoassays and other molecule binding assays that involve the use of a molecule in solution that changes the color of the solution or emits a fluorescent signal, where localization of nanoceria to organs or tissue is assessed by treatment with an oxidation sensitive dye or other detection devices.
    Type: Grant
    Filed: February 12, 2010
    Date of Patent: November 11, 2014
    Assignee: University of Central Florida Research Foundation, Inc.
    Inventors: J. Manuel Perez, Atul Asati, Santimukul Santra, Charalambos Kaittanis, Sudip Nath
  • Patent number: 8865068
    Abstract: Disclosed is an apparatus for analysis of a mixture of biological and/or chemical components that exposes a spatially arranged chosen component attached to magnetic particles to a magnetic field and records a magnetic induction signal from which the content of the biological and/or chemical components is determined. The magnetic field is alternating and has a pre-set spectrum at least at two frequencies. The apparatus records the signal at a frequency which is a linear combination of the at least two frequencies while the magnetic particles are exposed to the magnetic field.
    Type: Grant
    Filed: March 11, 2010
    Date of Patent: October 21, 2014
    Assignee: Magnisense Technology Limited
    Inventors: Petr Ivanovich Nikitin, Petr Mikhailovich Vetoshko
  • Patent number: 8815610
    Abstract: Magnetic nanoparticles are detected across a thin membrane that separates the nanoparticles from a magnetic sensor. The technique can be used in a medical context, in which an analyte of interest (present in a test fluid, such as blood) is attached to the membrane. Other compounds are in turn bound to the analyte, with one of these compounds including a magnetic nanoparticle that is then detected by the sensor. In this way, the analyte is detected by detecting the magnetic nanoparticle. By counting the number of magnetic nanoparticles, the concentration of the analyte in the test fluid can be determined.
    Type: Grant
    Filed: October 15, 2010
    Date of Patent: August 26, 2014
    Assignee: International Business Machines Corporation
    Inventors: David Berman, Qiu Dai, William Marvin Dyer, Wayne Isami Imaino, Alshakim Nelson
  • Patent number: 8696988
    Abstract: An automated in situ heat induced antigen recovery and staining method and apparatus for treating a plurality of microscope slides. The process of heat induced antigen recovery and the process of staining the biological sample on the microscope slide are conducted in the same apparatus, wherein the microscope slides do not need to be physically removed from one apparatus to another. Each treatment step occurs within the same reaction compartment. The reaction conditions of each reaction compartment for treating a slide can preferably be controlled independently, including the individualized application of reagents to each slide and the individualized treatment of each slide.
    Type: Grant
    Filed: January 15, 2013
    Date of Patent: April 15, 2014
    Inventor: Lee H. Angros
  • Patent number: 8691594
    Abstract: A method and apparatus for the manipulation of colloidal particulates and biomolecules at the interface between an insulating electrode such as silicon oxide and an electrolyte solution. Light-controlled electrokinetic assembly of particles near surfaces relies on the combination of three functional elements: the AC electric field-induced assembly of planar aggregates; the patterning of the electrolyte/silicon oxide/silicon interface to exert spatial control over the assembly process; and the real-time control of the assembly process via external illumination. The present invention provides a set of fundamental operations enabling interactive control over the creation and placement of planar arrays of several types of particles and biomolecules and the manipulation of array shape and size. The present invention enables sample preparation and handling for diagnostic assays and biochemical analysis in an array format, and the functional integration of these operations.
    Type: Grant
    Filed: October 31, 2012
    Date of Patent: April 8, 2014
    Assignee: Bioarray Solutions, Ltd.
    Inventor: Michael Seul
  • Patent number: 8679764
    Abstract: The invention provides a low-cost method for identifying and/or measuring a subpopulation of cells in a biological sample, such as a subpopulation of CD4-positive cells in a whole blood sample. In accordance with the invention, one or more cell surface markers are identified on a subpopulation of interest, which collectively are present in higher numbers on the cells of the subpopulation than on cells not in the subpopulation of interest. A probe comprising a binding compound and a density label are combined with the sample and the resulting mixture is centrifuged or sedimented through a density medium in a capillary. Labeled cells of interest pass through the density medium and stack at the bottom of the capillary where they may be visually detected and quantified by the height of the stack.
    Type: Grant
    Filed: March 3, 2009
    Date of Patent: March 25, 2014
    Assignee: Becton, Dickinson and Company
    Inventor: Hrair Kirakossian
  • Patent number: 8664008
    Abstract: An embodiment of the invention relates to a device for detecting an analyte in a sample. The device comprises a fluidic network and an integrated circuitry component. The fluidic network comprises a sample zone, a cleaning zone and a detection zone. The fluidic network contains a magnetic particle and/or a signal particle. A sample containing an analyte is introduced, and the analyte interacts with the magnetic particle and/or the signal particle through affinity agents. A microcoil array or a mechanically movable permanent magnet is functionally coupled to the fluidic network, which are activatable to generate a magnetic field within a portion of the fluidic network, and move the magnetic particle from the sample zone to the detection zone. A detection element is present which detects optical or electrical signals from the signal particle, thus indicating the presence of the analyte.
    Type: Grant
    Filed: July 6, 2012
    Date of Patent: March 4, 2014
    Assignee: Intel Corporation
    Inventors: David J. Liu, Kai Wu, Xing Su
  • Patent number: 8658093
    Abstract: System and methods for detecting analytes such as pathogenic cells are described. The methods allow for the direct measurement of analytes such as pathogenic organisms without the need for sample preparation and/or PCR. The devices can be used individually as point-of-use sensors for airborne pathogens and other pathogenic organisms in foods and agriculture products.
    Type: Grant
    Filed: July 3, 2008
    Date of Patent: February 25, 2014
    Assignee: Applied Biosystems, LLC
    Inventors: Aldrich N. K. Lau, Robert G. Eason, Kristian M. Scaboo, Handong Li
  • Patent number: 8642356
    Abstract: The present invention relates to a cascade enzyme-linked immunosorbent assay, more precisely a cascade enzyme-linked immunosorbent assay using magnetic microparticles (MMPs) immobilized with the target antigen specific primary antibody and silica nanoparticles (SPs) immobilized with a cascade reaction initiator and the antigen-specific secondary antibody. When the method of the present invention is applied in the detection of an antigen in biosamples, the detection sensitivity can be significantly increased.
    Type: Grant
    Filed: May 30, 2008
    Date of Patent: February 4, 2014
    Assignee: Korea Research Institute of Bioscience and Biotechnology
    Inventors: Sang Jeon Chung, Young-mi Lee, Yu-Jin Jeong, Hyo Jin Kang, Bong Hyun Chung